Skip to content

Global Venturing Review

Your weekly venturing review podcast

  • About the Podcast
  • Global Corporate Venturing
  • Global University Venturing
  • Global Impact Venturing
Global Venturing Review

Tag: Viola

11 December 2017 – Obsidian Therapeutics Raises $49.5m

http://media.blubrry.com/globalventuringreview/globalventuringreview.com/wp-content/uploads/2017/12/89-globalventuringreview-11dec2017.mp3

Podcast: Play in new window | Download

Subscribe: RSS

Covering the week’s venturing news including funding, investments, exits and people moves. This week’s episode includes: Fund news from Viola and GeneChem and deal news from Neon Therapeutics and Obsidian Therapeutics, plus much more.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

Author Global Venturing ReviewPosted on December 11, 2017December 10, 2017Tags "Neon Therapeutics", "Obsidian Therapeutics", corporate venturing, funding, GeneChem, government venturing, investment, IPO, university venturing, venture capital, ViolaLeave a comment on 11 December 2017 – Obsidian Therapeutics Raises $49.5m

Recent Posts

  • Mario Augusto Maia: Cogent Venture Partners
  • Jeffrey Grabow: EY
  • Dina Routhier & Michael Mahan – Stanley Ventures
  • Erin VanLanduit: Cargill Ventures
  • Raj Singh: JLL Spark Global Ventures

Categories

  • Podcast
  • About the Podcast
  • Global Corporate Venturing
  • Global University Venturing
  • Global Impact Venturing
Global Venturing Review Proudly powered by WordPress